查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1267715

靶向測序和重測序全球市場研究報告——2023-2030 年行業分析、規模、份額、增長、趨勢和預測

Global Targeted Sequencing And Resequencing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日期: | 出版商: Value Market Research | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格

靶向測序和重測序是兩種用於研究基因組特定區域的 DNA 測序技術。 靶向測序有選擇地對基因組內感興趣的特定區域進行測序。 這是通過使用設計用於僅結合和擴增所需 DNA 區域的探針或引物來實現的。 靶向測序可用於研究特定基因或感興趣區域，例如與特定疾病相關的基因或區域。 另一方面，重測序是對整個基因組或基因組特定區域進行測序，以識別遺傳變異和突變。 該技術可用於比較不同個體或人群的 DNA 序列，以確定可能與疾病或其他特徵相關的差異。

市場動態

精準醫學是利用遺傳信息制定個性化治療計劃。 靶向測序和重測序技術對於識別導致或促成疾病的基因突變以及製定個體化治療計劃是必不可少的。 癌症、罕見遺傳病和心血管疾病等遺傳性疾病的患病率在世界範圍內呈上升趨勢。 靶向測序和重測序技術是識別可能導致這些疾病的基因突變和開發靶向療法的重要工具。 測序技術的進步使靶向測序和重測序更快、更準確且成本更低。 這導致這些技術在研究和臨床環境中得到廣泛採用。 為了了解疾病的遺傳基礎並開發新的治療方法，各國政府對基因組研究進行了大量投資。 這推動了對靶向測序和重測序技術的需求。 人們越來越意識到基因檢測對疾病風險評估、家譜分析和個性化醫療的好處。 這推動了消費者基因組學市場對靶向測序和重測序服務的需求。

這份研究報告解釋了波特的五力模型、市場吸引力分析和價值鏈分析。 這些工具可幫助您清楚地了解您的行業結構並評估您在全球範圍內的競爭吸引力。 此外，這些工具還能夠全面評估全球靶向測序和重測序市場的每個細分市場。 靶向測序和重測序行業的發展和趨勢為這項研究提供了一種整體方法。

市場細分

本節提供有關靶向測序和再測序市場報告的國家和區域級部分的詳細數據，從而幫助戰略制定者確定目標受眾和他們各自產品或服務的即將到來的機會。它旨在支持

技術

  • 測序
  • 重測序（電泳重測序、Ngs、陣列重測序）

按申請

  • 臨床應用
  • 植物和動物科學
  • 藥物開發
  • 其他

按類型

  • 基於 DNA 的目標測序
  • 基於 RNA 的目標測序

按最終用途

  • 醫院和診所
  • 學術研究
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲、中東和非洲的靶向測序和重測序市場當前和未來的需求。 此外，該報告重點關注所有主要地區每個單獨應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的綜合概況和全球競爭格局的詳細視圖。 靶向測序和重測序市場的主要參與者是安捷倫科技、Illumina Inc.、F. Hoffmann-La Roche Ltd、GATC Biotech Ag、DNASTAR Inc.、QIAGEN、BGI、Oxford Nanopore Technology、Thermo Fisher Scientific, Inc. PerkinElmer、PacBio , RainDance Technologies Inc, Bio-Rad Laboratories, Integrated DNA Technologies, Pyriandex, Genomics, Macrogen Inc. 本節涵蓋主要併購、未來能力、合作夥伴關係、財務概覽、合作，它包括對競爭格局的概述，包括各種戰略開發，例如新產品開發和新產品發布。

如果您有任何定制要求，請寫信給我們。 我們的研究團隊可以根據您的需要提供定制報告。

內容

第一章前言

  • 報告內容
    • 目的
    • 目標受眾
    • USP（獨特的銷售建議）及其提供的內容
  • 調查範圍
  • 調查方法
    • 市場調研流程
    • 市場研究方法

第 2 章執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章靶向測序和重測序 - 行業分析

  • 簡介 - 市場動態
  • 市場驅動力
  • 市場製約因素
  • 機會
  • 行業趨勢
  • 波特的五力分析
  • 市場吸引力分析
    • 按技術進行市場吸引力分析
    • 市場吸引力分析：按應用
    • 按類型進行市場吸引力分析
    • 按最終用途進行的市場吸引力分析
    • 市場吸引力分析：按地區

第四章價值鏈分析

  • 價值鏈分析
  • 原材料分析
    • 原材料清單
    • 原材料製造商列表
    • 主要原材料價格走勢
  • 潛在買家名單
  • 營銷渠道
    • 直接營銷
    • 間接營銷
    • 市場發展趨勢

第 5 章靶向測序和重測序全球市場分析：按技術分類

  • 技術概述
  • 過去和未來的數據
  • 技術分析
  • 測序
  • 重測序（電泳重測序、Ngs、陣列重測序）

第 6 章靶向測序和重測序的全球市場分析：按應用

  • 總結：按應用
  • 過去和未來的數據
  • 分析：按應用
  • 臨床應用
  • 植物和動物科學
  • 藥物開發
  • 其他

第 7 章靶向測序和重測序的全球市場分析：按類型

  • 按類型概述
  • 過去和未來的數據
  • 按類型分析
  • 基於 DNA 的目標測序
  • 基於 RNA 的目標測序

第 8 章靶向測序和重測序的全球市場分析：按最終用途分類

  • 按最終用途匯總
  • 過去和未來的數據
  • 最終用途分析
  • 醫院和診所
  • 學術研究
  • 其他

第 9 章靶向測序和重測序全球市場分析：按地區

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、銷售業績和預測分析
    • 北美各部門的銷售分析
    • 北美銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、銷售業績和預測分析
    • 按細分市場進行的歐洲銷售分析
    • 按國家/地區劃分的歐洲銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 意大利銷售分析
    • 俄羅斯銷售分析
    • 其他歐洲銷售分析
  • 亞太地區銷售分析
    • 概覽、銷售業績和預測分析
    • 亞太地區各部門的銷售分析
    • 亞太國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本的銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 其他亞太地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、銷售業績和預測分析
    • 拉丁美洲各部門的銷售分析
    • 拉丁美洲國家/地區的銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利的銷售分析
    • 其他拉丁美洲銷售分析
  • 中東和非洲銷售分析
    • 概覽、銷售業績和預測分析
    • 中東和非洲各細分市場的銷售額分析
    • 中東和非洲國家/地區的銷售分析
    • 沙特阿拉伯銷售分析
    • 阿聯酋銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 其他中東和非洲銷售分析

第10章：靶向測序和重測序公司的競爭格局

  • 靶向測序和重測序市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他擴展

第11章公司簡介

  • 公司股票分析
  • 市場集中度
  • 安捷倫科技
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 因美納公司
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • F. Hoffmann-La Roche Ltd.
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • GATC 生物科技公司
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • DNASTAR 公司
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 凱傑
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 華大基因
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 牛津納米孔技術公司
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • Thermo Fisher Scientific Inc.
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 珀金埃爾默公司
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • PacBio
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • Rain Dance Technologies Inc.
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • Bio-Rad 實驗室公司
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • Integrated DNA Technologies Inc.
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • PierianDx
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • Genomatix 有限公司
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢
  • 宏基因公司
    • 公司概況
    • 企業收入
    • 產品介紹
    • 近期趨勢

注意：公司簡介中的財務細節和近期發展基於可用信息，私營公司可能不包括在內。

Product Code: VMR112110809

The global demand for Targeted Sequencing And Resequencing Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of XX% under the study period 2023 - 2030.

Targeted sequencing and resequencing are two types of DNA sequencing techniques used to study specific regions of the genome. Targeted sequencing involves selectively sequencing specific regions of interest within the genome. This is achieved by using probes or primers that are designed to bind to and amplify only the desired regions of DNA. Targeted sequencing is useful for studying specific genes or regions of interest, such as those associated with a particular disease. Resequencing, on the other hand, involves sequencing an entire genome or a specific region of the genome to identify genetic variations or mutations. This technique is useful for comparing the DNA sequences of different individuals or populations to identify differences that may be associated with disease or other traits.

Market Dynamics

Precision medicine involves using genetic information to develop personalized treatment plans for patients. Targeted sequencing and resequencing technologies are critical for identifying genetic mutations that can cause or contribute to disease and for developing personalized treatment plans. The prevalence of genetic diseases such as cancer, rare genetic disorders, and cardiovascular diseases is increasing globally. Targeted sequencing and resequencing technologies are important tools for identifying genetic mutations that may cause these diseases, as well as for developing targeted therapies. Advances in sequencing technologies have made targeted sequencing and resequencing faster, more accurate, and more affordable. This has led to wider adoption of these technologies in research and clinical settings. Heavy investment in genomics research by various governments and to understand the genetic basis of diseases and develop new treatments. This is driving the demand for targeted sequencing and resequencing technologies. There is a growing awareness among individuals about the benefits of genetic testing for disease risk assessment, ancestry analysis, and personalized medicine. This is driving the demand for targeted sequencing and resequencing services in the consumer genomics market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of targeted sequencing and resequencing. The growth and trends of targeted sequencing and resequencing industry provide a holistic approach to this study.

Market Segmentation

This section of the targeted sequencing and resequencing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

  • Sequencing
  • Re-Sequencing (Electrophoresis-Based Resequencing, Ngs, Array-Based Resequencing)

By Application

  • Clinical Application
  • Plant And Animal Sciences
  • Drug Development
  • Others

By Type

  • DNA-Based Targeted Sequencing
  • RNA-Based Targeted Sequencing

By End-Use

  • Hospitals & Clinics
  • Academic Research
  • Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Targeted Sequencing And Resequencing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the targeted sequencing and resequencing market include Agilent Technologies, Illumina Inc., F. Hoffmann-La Roche Ltd, GATC Biotech Ag, DNASTAR Inc., QIAGEN, BGI, Oxford Nanopore Technologies, Thermo Fisher Scientific Inc., Perkin Elmer Inc., PacBio, RainDance Technologies Inc., Bio-Rad Laboratories Inc., Integrated DNA Technologies Inc., PierianDx, Genomatix GmbH, Macrogen Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . TARGETED SEQUENCING AND RESEQUENCING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Technology
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By Type
    • 3.7.4 Market Attractiveness Analysis By End-Use
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY TECHNOLOGY

  • 5.1 Overview by Technology
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Technology
  • 5.4 Sequencing Historic and Forecast Sales by Regions
  • 5.5 Re-Sequencing (Electrophoresis-Based Resequencing, Ngs, Array-Based Resequencing) Historic and Forecast Sales by Regions

6 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Clinical Application Historic and Forecast Sales by Regions
  • 6.5 Plant And Animal Sciences Historic and Forecast Sales by Regions
  • 6.6 Drug Development Historic and Forecast Sales by Regions
  • 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY TYPE

  • 7.1 Overview by Type
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Type
  • 7.4 DNA-Based Targeted Sequencing Historic and Forecast Sales by Regions
  • 7.5 RNA-Based Targeted Sequencing Historic and Forecast Sales by Regions

8 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY END-USE

  • 8.1 Overview by End-Use
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-Use
  • 8.4 Hospitals & Clinics Historic and Forecast Sales by Regions
  • 8.5 Academic Research Historic and Forecast Sales by Regions
  • 8.6 Others Historic and Forecast Sales by Regions

9 . GLOBAL TARGETED SEQUENCING AND RESEQUENCING MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE TARGETED SEQUENCING AND RESEQUENCING COMPANIES

  • 10.1. Targeted Sequencing And Resequencing Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF TARGETED SEQUENCING AND RESEQUENCING INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Agilent Technologies
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Illumina Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. F. Hoffmann-La Roche Ltd
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. GATC Biotech Ag
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. DNASTAR Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. QIAGEN
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. BGI
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Oxford Nanopore Technologies
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Thermo Fisher Scientific Inc.
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Perkin Elmer Inc.
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. PacBio
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. RainDance Technologies Inc.
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Bio-Rad Laboratories Inc.
    • 11.15.1. Company Overview
    • 11.15.2. Company Revenue
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. Integrated DNA Technologies Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Company Revenue
    • 11.16.3. Products
    • 11.16.4. Recent Developments
  • 11.17. PierianDx
    • 11.17.1. Company Overview
    • 11.17.2. Company Revenue
    • 11.17.3. Products
    • 11.17.4. Recent Developments
  • 11.18. Genomatix GmbH
    • 11.18.1. Company Overview
    • 11.18.2. Company Revenue
    • 11.18.3. Products
    • 11.18.4. Recent Developments
  • 11.19. Macrogen Inc.
    • 11.19.1. Company Overview
    • 11.19.2. Company Revenue
    • 11.19.3. Products
    • 11.19.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Technology (USD MN)
  • Sequencing Market Sales by Geography (USD MN)
  • Re-Sequencing (Electrophoresis-Based Resequencing, Ngs, Array-Based Resequencing) Market Sales by Geography (USD MN)
  • Analysis Market by Application (USD MN)
  • Clinical Application Market Sales by Geography (USD MN)
  • Plant And Animal Sciences Market Sales by Geography (USD MN)
  • Drug Development Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Type (USD MN)
  • DNA-Based Targeted Sequencing Market Sales by Geography (USD MN)
  • RNA-Based Targeted Sequencing Market Sales by Geography (USD MN)
  • Analysis by End-Use (USD MN)
  • Hospitals & Clinics Market Sales by Geography (USD MN)
  • Academic Research Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Targeted Sequencing And Resequencing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Targeted Sequencing And Resequencing Report
  • Market Research Process
  • Market Research Methodology
  • Global Targeted Sequencing And Resequencing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Technology
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by End-Use
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Technology (USD MN)
  • Sequencing Market Sales by Geography (USD MN)
  • Re-Sequencing (Electrophoresis-Based Resequencing, Ngs, Array-Based Resequencing) Market Sales by Geography (USD MN)
  • Global Market Analysis by Application (USD MN)
  • Clinical Application Market Sales by Geography (USD MN)
  • Plant And Animal Sciences Market Sales by Geography (USD MN)
  • Drug Development Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Type (USD MN)
  • DNA-Based Targeted Sequencing Market Sales by Geography (USD MN)
  • RNA-Based Targeted Sequencing Market Sales by Geography (USD MN)
  • Global Market Analysis by End-Use (USD MN)
  • Hospitals & Clinics Market Sales by Geography (USD MN)
  • Academic Research Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.